SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral informs about acquisition

04 Jun 2025 Evaluate
Epigral has informed regarding execution of Share Subscription and Shareholders' Agreement and Energy Supply Agreement for Power Purchase through Renewable resources. 

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1115.65 15.00 (1.36%)
13-Apr-2026 12:11 View Price Chart
Peers
Company Name CMP
BASF India 3602.50
Tata Chemicals 729.20
SRF 2451.75
Pidilite Inds. 1329.90
Deepak Nitrite 1460.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×